lcp
We have detected you are using Internet Explorer. To provide the best and most secure experience, please use a modern browser as we do not support Internet Explorer.

Clinical Opal #7 - Ovarian cancer screening

22 October 2021 - Dr Simon Morgan

Anna Li, a 46 year old high school teacher, presents to you for follow up after a recent metatarsal fracture. At the end of the visit, she asks you whether she can be screened for ovarian cancer.

She tells you that one of the other teachers at her school had just been diagnosed and she has become aware that 'there is a blood test that can pick it up early'. She has been very worried about it since her colleague was diagnosed.

Anna is fit and well and has no symptoms on further questioning. She has no family history of breast or ovarian cancer. Her last CST was 2 years ago and normal.

How would you respond to Anna's request?

 

A clinical practice guideline published in JAMA in 2018 stated that there is clear evidence that screening for ovarian cancer does not reduce ovarian cancer mortality.1 Furthermore, there is evidence that the harms from screening for ovarian cancer can be substantial, including unnecessary surgery for women who have false positive tests. They concluded that the harms of screening for ovarian cancer outweigh the benefit.

This is reflected in the RACGP Guidelines for Preventive Activities in General Practice (Red Book)2 and in the recommendations of Choosing Wisely Australia.3

Anna should therefore be informed that screening for ovarian cancer in asymptomatic, low-risk women like herself is not recommended due to the low sensitivity and specificity of available tests. This requires a sensitive and patient-centred discussion on the benefits and harms of screening.

 

References

  1. US Preventive Services Task Force. Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2018.319;6:588-594.
  2. RACGP Preventive Activities in General Practice
  3. Choosing Wisely Australia website
Dr Simon Morgan
Dr Simon Morgan

Simon is a GP based in Newcastle, NSW, and a senior medical educator with Medcast.  He also has medical education roles with the RACGP and GPSA.

Over the past three decades, Simon has worked in clinical and educational roles in NSW and the NT, as well as in the Republic of Ireland. He has published over 75 peer reviewed journal articles, and in 2018 received the RACGP Corliss award for his contribution to medical education.

Simon is passionate about high quality education and training. He has particular interests in GP supervisor professional development and the rational use of tests and medicines. He is a proud member of Doctors for the Environment. He spends his spare time drinking craft beer and pretending that he is a musician in the Euthymics, an all-GP band.

Read more
Get Medcast Plus

Become a member and get unlimited access to 100s of hours of premium education.

Learn more
Related News
Intellectual Disability and Consent and Decision-Making - Clinical Opal

Council for Intellectual Disability

This article addresses challenges in managing the healthcare needs of Minh, who is a patient with an intellectual disability and complex communication needs. It emphasises the importance of understanding individual communication methods, obtaining proper consent, and collaborating with support teams.

5 mins READ
Ling has left hemiparesis and is aphasic following stroke, what comes next?

Jenny Browne

67-year-old Ling, recently relocated from China, was admitted to the stroke unit post-thrombolysis for an ischaemic stroke. When should early stroke rehabilitation begin and what should this entail?

5 mins READ
Clinical Opal - Harriet presents with unmanaged anxiety

Dr Simon Morgan

Harriet is a 22-year-old university student who presents to you with severe anxiety.

5 mins READ